Larvol Delta - Compelling-Data-in-Breast-Cancer-Treatment-with-FirstInClass-Cyclin-AB-Inhibitor-Presented-at-2023-AACRNCIEORTC-International-Conference

CID-078 - Circle Pharma

https://www.businesswire.com/news/home/20231023747006/en/Compelling-Data-in-Breast-Cancer-Treatment-with-First-In-Class-Cyclin-AB-Inhibitor-Presented-at-2023-AACR-NCI-EORTC-International-Conference

Oct 23, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next